Skip to main content

Aurora Daljit Singh's Form 4 filing

Neumora Therapeutics, Inc. (NMRA) · filed Aug 19, 2026

Accession no.
0001610717-26-000362
Filed
Aug 19, 2026, 7:17 PM ET
Trade date
Aug 17-19, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 18 non-derivative transactions and 11 derivative transactions. Open-market sales total $431.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Aurora Daljit SinghCIK 0001793971Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 17, 2026Common StockMOption exerciseAcquired+40,890$0.72+$29,440.8123,660Direct
Aug 17, 2026Common StockMOption exerciseAcquired+15,355$0.72+$11,055.6139,015Direct
Aug 17, 2026Common StockMOption exerciseAcquired+1,424$0.72+$1,025.28140,439Direct
Aug 17, 2026Common StockMOption exerciseAcquired+1$0.72+$0.72140,440Direct
Aug 17, 2026Common StockSSaleDisposed−57,670$1.51F1−$86,822.1982,770Direct
Aug 17, 2026Common StockSSaleDisposed−34,020$1.49F2−$50,529.9148,750Direct
Aug 17, 2026Common StockMOption exerciseAcquired+25,279$0.72+$18,200.8825,279Indirect
Aug 17, 2026Common StockMOption exerciseAcquired+29,737$0.72+$21,410.6455,016Indirect
Aug 17, 2026Common StockSSaleDisposed−55,016$1.50F4−$82,782.580Indirect
Aug 18, 2026Common StockMOption exerciseAcquired+34,162$0.72+$24,596.6482,912Direct
Aug 18, 2026Common StockSSaleDisposed−34,162$1.58F9−$54,136.5248,750Direct
Aug 18, 2026Common StockMOption exerciseAcquired+34,987$0.72+$25,190.6434,987Indirect
Aug 18, 2026Common StockSSaleDisposed−34,987$1.59F10−$55,485.880Indirect
Aug 19, 2026Common StockMOption exerciseAcquired+13,268$0.72+$9,552.9662,018Direct
Aug 19, 2026Common StockMOption exerciseAcquired+17,732$0.72+$12,767.0479,750Direct
Aug 19, 2026Common StockSSaleDisposed−31,000$1.65F11−$51,029.148,750Direct
Aug 19, 2026Common StockMOption exerciseAcquired+30,918$0.72+$22,260.9630,918Indirect
Aug 19, 2026Common StockSSaleDisposed−30,918$1.65F12−$50,887.940Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 17, 2026Common StockMOption exerciseDisposed−40,890$0.00$00Direct
Aug 17, 2026Common StockMOption exerciseDisposed−15,355$0.00$0192,546Direct
Aug 17, 2026Common StockMOption exerciseDisposed−1,424$0.00$070,797Direct
Aug 17, 2026Common StockMOption exerciseDisposed−1$0.00$0999,999Direct
Aug 17, 2026Common StockMOption exerciseDisposed−25,279$0.00$0110,931Indirect
Aug 17, 2026Common StockMOption exerciseDisposed−29,737$0.00$00Indirect
Aug 18, 2026Common StockMOption exerciseDisposed−34,162$0.00$036,635Direct
Aug 18, 2026Common StockMOption exerciseDisposed−34,987$0.00$075,944Indirect
Aug 19, 2026Common StockMOption exerciseDisposed−13,268$0.00$023,367Direct
Aug 19, 2026Common StockMOption exerciseDisposed−17,732$0.00$0177,268Direct
Aug 19, 2026Common StockMOption exerciseDisposed−30,918$0.00$045,026Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F2

This transaction was executed in multiple trades at prices ranging from $1.46 to $1.5277, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $1.49 to $1.645, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $1.48 to $1.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $1.62 to $1.6995, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F12

This transaction was executed in multiple trades at prices ranging from $1.62 to $1.7006, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Remarks

Title: Chief Operating and Development Officer

Read the full filing on SEC EDGAR (opens in a new tab)